CDK4 and cancer: Growing evidence demonstrates that CDK4 is a “metabolic” cell-cycle regulator17,18 and is involved in fatty acid metabolism,19 while metformin changes the metabolism of mitochondria through inhibition of respiratory-chain complex 1.1 Therefore, we explored whether the synergy of the combination treatment was due to changes in the metabolome of cancer cells.